Obesity-Related Chronic Kidney Disease-The Role of Lipid Metabolism

• Published in: Metabolites 2015-12, Vol.5 (4), p.720-732
• Main Authors: Mount, Peter, Davies, Matthew, Choy, Suet-Wan, Cook, Natasha, Power, David
• Format: Article
• Language: English
• Subjects: acetyl-CoA carboxylase; AMP-activated protein kinase; chronic kidney disease; high fat diet; lipid metabolism; mesangial cell; obesity; podocyte; proximal tubule; Review
• ISSN: 2218-1989; 2218-1989
• DOI: 10.3390/metabo5040720

Obesity is an independent risk factor for chronic kidney disease (CKD). The mechanisms linking obesity and CKD include systemic changes such as high blood pressure and hyperglycemia, and intrarenal effects relating to lipid accumulation. Normal lipid metabolism is integral to renal physiology and disturbances of renal lipid and energy metabolism are increasingly being linked with kidney disease. AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) are important regulators of fatty acid oxidation, which is frequently abnormal in the kidney with CKD. A high fat diet reduces renal AMPK activity, thereby contributing to reduced fatty acid oxidation and energy imbalance, and treatments to activate AMPK are beneficial in animal models of obesity-related CKD. Studies have found that the specific cell types affected by excessive lipid accumulation are proximal tubular cells, podocytes, and mesangial cells. Targeting disturbances of renal energy metabolism is a promising approach to addressing the current epidemic of obesity-related kidney disease.